Sabina Rizvi - 21 Dec 2021 Form 4 Insider Report for MusclePharm Corp (MSLP)

Role
President & CFO, Director
Signature
/s/ Sabina Rizvi
Issuer symbol
MSLP
Transactions as of
21 Dec 2021
Net transactions value
$0
Form type
4
Filing time
28 Jul 2022, 16:17:42 UTC
Previous filing
28 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MSLP Options (right to buy) Award $0 +1,811,000 $0.000000 1,811,000 21 Dec 2021 Common stock 1,811,000 $0.4000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options were granted pursuant to MusclePharm Corporation's 2021 Omnibus Equity Incentive Plan and vested fully on April 1, 2022.